Herpetic Keratitis Following Corneal Crosslinking for Keratoconus: A Case Series

References

• Godefrooij DA, Gans R, Imhof SM, et al. Nationwide reduction in the number of corneal transplantations for keratoconus following the implementation of cross-linking. Acta Ophthalmol. 2016;94(7):675–678. doi:10.1111/aos.13095
   PubMed Web of Science ®Google Scholar
• Subasinghe SK, Ogbuehi KC, Dias GJ. Current perspectives on corneal collagen crosslinking (CXL). Graefe’s Arch Clin Experiment Ophthalmol. 2018;256(8):1363–1384. doi:10.1007/s00417-018-3966-0
   PubMed Web of Science ®Google Scholar
• Angelo L, Gokul Boptom A, McGhee C, et al. Corneal crosslinking: present and future. Asia Pacific j Ophthalmol. 2022;11(5):441–452. doi:10.1097/APO.0000000000000557
   Web of Science ®Google Scholar
• Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi:10.1016/S0002-9394(02)02220-1
   PubMed Web of Science ®Google Scholar
• Borroni D, Paytuví-Gallart A, Sanseverino W, et al. Exploring the healthy eye microbiota niche in a multicenter study. Int J Mol Sci. 2022;23(18):10229. doi:10.3390/ijms231810229
   PubMed Web of Science ®Google Scholar
• Chen CY, Shen JH, Huang YC. Seroepidemiology of Epstein-Barr virus and herpes simplex virus-1 in Taiwan. Int J Antimicrob Agents. 2013;42:S135. doi:10.1016/S0924-8579(13)70535-1
   Web of Science ®Google Scholar
• Toma HS, Murina AT, Areaux RG, et al. Ocular HSV-1 latency, reactivation and recurrent disease. Semin Ophthalmol. 2008;23(4):249–273. doi:10.1080/08820530802111085
   Google Scholar
• Parekh M, Romano V, Franch A, et al. Shotgun sequencing to determine corneal infection. Am J Ophthalmol Case Rep. 2020;19:100737. doi:10.1016/j.ajoc.2020.100737
   PubMedGoogle Scholar
• Borroni D. Granulicatella adiacens as an unusual cause of microbial keratitis: a metagenomic approach. Ocul Immunol Inflamm. 2021;1–2. doi:10.1080/09273948.2021.1933066
   Web of Science ®Google Scholar
• Borroni D, Romano V, Kaye SB, et al. Metagenomics in ophthalmology: current findings and future prospectives. BMJ Open Ophthalmol. 2019;4(1):e000248. doi:10.1136/bmjophth-2018-000248
   PubMed Web of Science ®Google Scholar
• Kymionis GD, Portaliou DM, Bouzoukis DI, et al. Herpetic keratitis with iritis after corneal crosslinking with riboflavin and ultraviolet A for keratoconus. J Cataract Refract Surg. 2007;33(11):1982–1984. doi:10.1016/j.jcrs.2007.06.036
   PubMed Web of Science ®Google Scholar
• Sitaula S, Singh SK, Gurung A. Bilateral viral keratitis following corneal collagen crosslinking for progressive keratoconus. J Ophthalmic Inflamm Infect. 2019;9(1). doi:10.1186/s12348-019-0185-8
   Web of Science ®Google Scholar
• Al-Qarni A, Alharbi M. Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-A for keratoconus. Middle East Afr J Ophthalmol. 2015;22(3):389–392. doi:10.4103/0974-9233.159777
   Google Scholar
• Yuksel N, Bilgihan K, Hondur AM. Herpetic keratitis after corneal collagen cross-linking with riboflavin and ultraviolet-A for progressive keratoconus. Int Ophthalmol. 2011;31(1):1–3. doi:10.1007/s10792-011-9489-x
   Google Scholar
• Santodomingo-Rubido J, Carracedo G, Suzaki A, et al. Keratoconus: an updated review. Contact Lens Anterior Eye. 2022;45(3). doi:10.1016/j.clae.2021.101559
   Google Scholar
• Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186(SUPPL.1):S3–S28. doi:10.1086/343739
   PubMed Web of Science ®Google Scholar
• Kaufman HE, Azcuy AM, Varnell ED, et al. HSV-1 DNA in tears and saliva of normal adults. Invest Ophthalmol Vis Sci. 2005;46(1):241–247. doi:10.1167/iovs.04-0614
   PubMed Web of Science ®Google Scholar
• McCormick I, James C, Welton NJ, et al. Incidence of herpes simplex virus keratitis and other ocular disease: global review and estimates. Ophthalmic Epidemiol. 2021;29(4):353–362. doi:10.1080/09286586.2021.1962919
   Web of Science ®Google Scholar
• Gabison EE, Saad S, Doan S, et al. Epidemiology of neurotrophic keratitis: prevalence, etiologies, outcomes and clinical management. Invest Ophthalmol Vis Sci. 2018;59(9):1800.
   Web of Science ®Google Scholar
• Nath P, Kabir MA, Doust SK, et al. Diagnosis of herpes simplex virus: laboratory and point-of-care techniques. Infect Dis Rep. 2021;13(2):518–539. doi:10.3390/idr13020049
   PubMed Web of Science ®Google Scholar
• Van Rooij J, Rijneveld WJ, Remeijer L, et al. Effect of oral Acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial. Ophthalmology. 2003;110(10):1916–1919. doi:10.1016/S0161-6420(03)00798-X
   Web of Science ®Google Scholar
• Ghosh S, Jhanji V, Lamoureux E, et al. Acyclovir therapy in prevention of recurrent herpetic keratitis following penetrating keratoplasty. Am J Ophthalmol. 2008;145(2):198–202.e192. doi:10.1016/j.ajo.2007.10.005
   Web of Science ®Google Scholar
• De Rojas Silva MV, Díez-Feijóo E, Javaloy J, et al. Prophylactic perioperative antiviral therapy for LASIK in patients with inactive herpetic keratitis. J Refract Surg. 2006;22(4):404–406. doi:10.3928/1081-597x-20060401-19
   Web of Science ®Google Scholar
• Moshirfar M, Milner DC, Baker PA, et al. Corneal refractive surgery in patients with a history of herpes simplex keratitis: a narrative review. Clin Ophthalmol. 2020;14:3891–3901. doi:10.2147/OPTH.S282070
   Web of Science ®Google Scholar
• O’Brien JJ, Campoli-Richards DM. Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1989;37(3):233–309. doi:10.2165/00003495-198937030-00002
   PubMed Web of Science ®Google Scholar
• Van Velzen M, Van De Vijver DAMC, Van Loenen FB, et al. Acyclovir prophylaxis predisposes to antiviral-resistant recurrent herpetic keratitis. J Infect Dis. 2013;208(9):1359–1365. doi:10.1093/infdis/jit350
   PubMed Web of Science ®Google Scholar